Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture

Cell Reports Medicine - Tập 2 - Trang 100382 - 2021
Haoyang Mi1, Trinity J. Bivalacqua2,3, Max Kates3, Roland Seiler4, Peter C. Black5, Aleksander S. Popel1,2, Alexander S. Baras2,3,6
1Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA
2Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA
3James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
4Department of Urology, University Hospital Bern, Bern, Switzerland
5Department of Urologic Sciences, University of British Columbia Faculty of Medicine, Vancouver, BC, Canada
6Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD USA.

Tài liệu tham khảo

Howlader, 2017, 1 Ghosh, 2014, Targeted therapies in urothelial carcinoma, Curr. Opin. Oncol., 26, 305, 10.1097/CCO.0000000000000064 Grossman, 2003, Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer, N. Engl. J. Med., 349, 859, 10.1056/NEJMoa022148 Motterle, 2020, Predicting response to neoadjuvant chemotherapy in bladder cancer, Eur. Urol. Focus, 6, 642, 10.1016/j.euf.2019.10.016 Vale, 2005, Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration, Eur. Urol., 48, 202, 10.1016/j.eururo.2005.04.006 Guo, 2020, Assessment of luminal and basal phenotypes in bladder cancer, Sci. Rep., 10, 9743, 10.1038/s41598-020-66747-7 Tse, 2019, Molecular predictors of complete response following neoadjuvant chemotherapy in urothelial carcinoma of the bladder and upper tracts, Int. J. Mol. Sci., 20, 793, 10.3390/ijms20040793 Litjens, 2018, 1399 H&E-stained sentinel lymph node sections of breast cancer patients: the CAMELYON dataset, Gigascience, 7, giy065, 10.1093/gigascience/giy065 Campanella, 2019, Clinical-grade computational pathology using weakly supervised deep learning on whole slide images, Nat. Med., 25, 1301, 10.1038/s41591-019-0508-1 Baras, 2016, The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder, OncoImmunology, 5, e1134412, 10.1080/2162402X.2015.1134412 Baras, 2015, Identification and validation of protein biomarkers of response to neoadjuvant platinum chemotherapy in muscle invasive urothelial carcinoma, PLoS ONE, 10, e0131245, 10.1371/journal.pone.0131245 Gandhi, 2015, Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: predicting response and assessing outcomes, Urol. Oncol., 33, 204.e1, 10.1016/j.urolonc.2015.02.011 Kiss, 2017, Her2 alterations in muscle-invasive bladder cancer: patient selection beyond protein expression for targeted therapy, Sci. Rep., 7, 42713, 10.1038/srep42713 Fleischmann, 2014, Tumor regression grade of urothelial bladder cancer after neoadjuvant chemotherapy: a novel and successful strategy to predict survival, Am. J. Surg. Pathol., 38, 325, 10.1097/PAS.0000000000000142 Seiler, 2017, Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy, Eur. Urol., 72, 544, 10.1016/j.eururo.2017.03.030 Bankhead, 2017, QuPath: open source software for digital pathology image analysis, Sci. Rep., 7, 16878, 10.1038/s41598-017-17204-5 Guy, 2018, Evaluation of image registration accuracy for tumor and organs at risk in the thorax for compliance with TG 132 recommendations, Adv. Radiat. Oncol., 4, 177, 10.1016/j.adro.2018.08.023 Schmidt, 2018, Cell detection with star-convex polygons, 265 Lee, 2013, Cell orientation entropy (COrE): predicting biochemical recurrence from prostate cancer tissue microarrays, 396 Wang, 2017, Prediction of recurrence in early stage non-small cell lung cancer using computer extracted nuclear features from digital H&E images, Sci. Rep., 7, 13543, 10.1038/s41598-017-13773-7 Claramunt, 2005, A spatial form of diversity, 218 Failmezger, 2020, Topological tumor graphs: a graph-based spatial model to infer stromal recruitment for immunosuppression in melanoma histology, Cancer Res., 80, 1199, 10.1158/0008-5472.CAN-19-2268 Pageon, 2016, Clus-DoC: a combined cluster detection and colocalization analysis for single-molecule localization microscopy data, Mol. Biol. Cell, 27, 3627, 10.1091/mbc.e16-07-0478 Joseph, 2019, Immune responses in bladder cancer-role of immune cell populations, prognostic factors and therapeutic implications, Front. Oncol., 9, 1270, 10.3389/fonc.2019.01270 Taber, 2020, Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis, Nat. Commun., 11, 4858, 10.1038/s41467-020-18640-0 Witkiewicz, 2011, The meaning of p16(ink4a) expression in tumors: functional significance, clinical associations and future developments, Cell Cycle, 10, 2497, 10.4161/cc.10.15.16776 Mendenhall, 2009, Human papillomavirus and head and neck cancer, Am. J. Clin. Oncol., 32, 535, 10.1097/COC.0b013e31818b8fee Cheng, 2020, Computational analysis of pathological images enables a better diagnosis of TFE3 Xp11.2 translocation renal cell carcinoma, Nat. Commun., 11, 1778, 10.1038/s41467-020-15671-5 Xu, 2020, Computerized classification of prostate cancer gleason scores from whole slide images, IEEE/ACM Trans. Comput. Biol. Bioinform., 17, 1871, 10.1109/TCBB.2019.2941195 Cheng, 2018, Identification of topological features in renal tumor microenvironment associated with patient survival, Bioinformatics, 34, 1024, 10.1093/bioinformatics/btx723 Chandramouli, 2020, Computer extracted features from initial H&E tissue biopsies predict disease progression for prostate cancer patients on active surveillance, Cancers (Basel), 12, 2708, 10.3390/cancers12092708 Marusyk, 2020, Intratumor heterogeneity: the rosetta stone of therapy resistance, Cancer Cell, 37, 471, 10.1016/j.ccell.2020.03.007 Mi, 2020, Digital pathology analysis quantifies spatial heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 immune markers in triple-negative breast cancer, Front. Physiol., 11, 583333, 10.3389/fphys.2020.583333 Heindl, 2015, Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology, Lab. Invest., 95, 377, 10.1038/labinvest.2014.155 Gong, 2019, Quantitative characterization of CD8+ T cell clustering and spatial heterogeneity in solid tumors, Front. Oncol., 8, 649, 10.3389/fonc.2018.00649 Ho, 2020, Integrated immunological analysis of a successful conversion of locally advanced hepatocellular carcinoma to resectability with neoadjuvant therapy, J. Immunother. Cancer, 8, e000932, 10.1136/jitc-2020-000932 Yarchoan, 2021, Feasibility and efficacy of neoadjuvant cabozantinib and nivolumab in patients with borderline resectable or locally advanced hepatocellular carcinoma (HCC), J. Clin. Oncol., 39, 335, 10.1200/JCO.2021.39.3_suppl.335 Virtanen, 2020, SciPy 1.0: fundamental algorithms for scientific computing in Python, Nat. Methods, 17, 261, 10.1038/s41592-019-0686-2